Jump to content
RemedySpot.com

Zovant-- Long-sought drug said to fight sepsis

Rate this topic


Guest guest

Recommended Posts

CNN.com - Health - Long-sought drug said to fight sepsis - February 9, 2001

SEARCH CNN.com CNNSI.com CNNfn.com The Web

CNN Sites CNN CNN Asia CNN Europe CNNfn CNNSI myCNN Education

AllPolitics Languages

MAINPAGE

WORLD

US

WEATHER

BUSINESS

SPORTS

POLITICS

LAW

SCI-TECH

SPACE

HEALTH

ENTERTAINMENT

TRAVEL

CAREER

LOCAL

IN-DEPTH

Click Here

EDITIONS:

CNN.com Asia

CNN.com Europe

set default edition

MULTIMEDIA:

video

audio

multimedia showcase

more services

E-MAIL:

Subscribe to one of our news e-mail lists.

Enter your address:

DISCUSSION:

message boards

chat

feedback

CNN WEB SITES:

CNNfyi.com

CNN.com Europe

CNN.com Asia

Spanish

Portuguese

German

Italian

Swedish

Norwegian

Danish

Japanese

Chinese Headlines

Korean Headlines

TIME INC. SITES:

Go To ... Time.com People Money Fortune EW

CNN NETWORKS:

CNN anchors

transcripts

distribution

SITE INFO:

search

ad info

jobs

WEB SERVICES:

Long-sought drug said to fight sepsis

BOSTON, Massachusetts (AP) -- An international research team says it has

discovered the first drug that successfully combats sepsis, a blood infection

that kills about 225,000 Americans each year.

Researchers have spent about 15 years looking for a drug to fight the

disease.

" From what we saw, this is a tremendous breakthrough, " said Dr.

Matthay of the University of California in San Francisco. " This is truly a

landmark trial. "

Matthay reviewed the test results with other scientists for The New

England Journal of Medicine.

The findings were initially set to be published March 8, but the journal

is releasing them earlier because of their medical importance.

The research was carried out on 1,690 patients with severe sepsis at 164

locations in 11 countries. It was coordinated at Vanderbilt University in

Nashville, Tennessee, and funded by Eli Lilly and Co.

Much of the public has never heard of sepsis, even though about 750,000

cases are diagnosed in the U.S. each year, researchers say. Many medical

problems give rise to sepsis, including pneumonia, trauma, surgical

complications and cancer.

Sepsis, a bacterial infection of the bloodstream, sets off a chain of

chemical reactions that lead to excessive inflammation and clotting. It often

causes death by destroying a patient's internal organs.

The new drug is derived from a natural blood product known as activated

protein C. In the blood, activated protein C curbs inflammation and clotting.

Sepsis patients are currently treated with antibiotics, fluids and

ventilators for lung failure. But no existing treatment directly attacks the

blood infection.

Dr. Goodman, a University of Washington researcher who has studied

sepsis, said the new drug " gives us a new bullet to shoot at this disease. "

In the study, half of the patients took the drug intravenously for four

days, and the rest took a placebo. The patients were monitored for 28 days.

While only 25 percent of the patients given the drug died, 31 percent died

in the comparison group. Patients who took the drug had a 19 percent lesser

chance of dying than the others.

" It's been a terrible frustration as an intensive-care doctor to watch

huge numbers of patients who develop sepsis, " said lead researcher Gordon

Bernard of Vanderbilt. " This drug will be used widely for these patients. "

Eli Lilly has applied for approval from the U.S. Food and Drug

Administration, and plans to market the drug under the name Zovant. Bernard, who

has acted as a consultant for Lilly, said approval could come within six months.

Researchers in the study acknowledged that the drug may yield some

negative side effects. Of the patients who took the drug, 3.5 percent developed

serious bleeding, compared with 2 percent of placebo-takers. But doctors said

even a 3.5 percent risk is fairly small.

Still, they said the drug should not be given to patients who are

susceptible to bleeding. They also said the drug has not yet been tested on

children.

Copyright 2001 The Associated Press. All rights reserved. This material

may not be published, broadcast, rewritten, or redistributed.

--------------------------------------------------------------------------

RELATED STORIES:

Potentially fatal germs under fingernails of hospital personnel should

be 'eradicated,' study says

September 7, 2000

New fabric may help fight transmittable diseases

August 24, 1999

New York man dies after supergerm infection

April 24, 1998

--------------------------------------------------------------------------

RELATED SITES:

New England Journal of Medicine

Eli Lilly and Co.

Vanderbilt University

Food and Drug Administration

University of California San Francisco

University of Washington

Note: Pages will open in a new browser window

External sites are not endorsed by CNN Interactive.

--------------------------------------------------------------------------

Search CNN.com CNNSI.com CNNfn.com The Web

HEALTH

Genome study: Humans have remarkably few genes

Australian doctors reject economy class syndrome

Two indicted in deaths of nursing home patients

Abuse of prescription painkiller spreads

Pulled drugs may be riskier for women

Lasting mental loss after heart surgery possible

(MORE)

--------------------------------------------------------------------------

--------------------------------------------------------------------------

TOP STORIES

Astronauts explore Destiny

Search for ship survivors resumes as hopes fade

Appeals court to rule in Napster case Monday

Genome study: Humans have remarkably few genes

(MORE)

--------------------------------------------------------------------------

BUSINESS

When Greenspan speaks

Napster: Another judgment day

Riverstone leads IPO week

(MORE)

MARKETS 4:31pm ET, 2/9

DJIA 99.10 10781.40

NAS 91.09 2470.97

S & P 17.77 1314.76

--------------------------------------------------------------------------

SPORTS

Gripes and injuries dominate NBA All-Star talk

holds off Earnhardt to win Bud Shootout

Rejuvenated Ga. Tech downs No. 6 Virginia, 62-56

(MORE)

All Scoreboards

--------------------------------------------------------------------------

WEATHER

All cities

--------------------------------------------------------------------------

WORLD

Search for ship survivors resumes as hopes fade

--------------------------------------------------------------------------

U.S.

Astronauts explore Destiny

--------------------------------------------------------------------------

ALLPOLITICS

Burton seeks immunity for Marc Rich's ex-wife

--------------------------------------------------------------------------

LAW

Questionnaires yield portrait of bombings trial jury

--------------------------------------------------------------------------

SCI-TECH

Astronauts enter Destiny for first time

--------------------------------------------------------------------------

ENTERTAINMENT

Review: Grisham's 'Painted House' brightly done

--------------------------------------------------------------------------

TRAVEL

Delta pilots vote on whether to authorize strike

--------------------------------------------------------------------------

CAREER

Opening notes

--------------------------------------------------------------------------

(MORE HEADLINES)

Back to the top © 2001 Cable News Network. All Rights Reserved.

Terms under which this service is provided to you.

Read our privacy guidelines.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...